reuters group lawmaker call national institutes health department health human service step reduce cost medivation inc ’s astellas pharma inc ’s prostate cancer drug xtandi
letter sign democratic us presidential candidate bernie sander rep lloyd doggett dtexas peter welch dvt lawmaker urge nih hold public hearing consider override patent xtandi make drug available low price
medication average wholesale price united states 129000 sell japan sweden 39000 canada 30000 accord lawmaker ’ letter address hhs secretary sylvia burwell nih director francis collin
-PRON- note federal fund support development drug base research university california los angeles conduct taxpayersupported grant
" americans pay research result pharmaceutical drug available reasonable price " say doggett cochair house democratic caucus prescription drug task force
" unaffordable drug 100 percent ineffective " spokesman astella say 81 percent privately insure patient pay 25 less pocket per month medication 2015 79 percent medicare patient pay nothing pocket
eligible patient insurance underinsured annual adjust household income 100000 less astella provide xtandi free spokesman tyler marciniak say
20000 man treat xtandi last year 2000 receive drug free -PRON- add
prostate cancer one common cancer america affect one seven man accord american cancer society
us lawmaker presidential candidate recent month step criticism us drug price trend raise investor concern future price cut could hurt pharmaceutical biotech company
" united states government use every tool available lower outrageously high prescription drug price " sander say
" nih power stop blatant profiteering put pharmaceutical industry notice era charge unconscionable price must end " medivation could reach comment
spokesman nih hhs could reach
also sign letter sen
al franken dminn sheldon whitehouse dri amy klobuchar dminn patrick leahy dvt elizabeth warren dmass
well rep elijah cumming dmd
jan schakowsky dill rosa delauro dconn mark pocan dwis